Brahmar Cellulose develops, produces and markets microcrystalline cellulose (MCC) and sodium carboxyl methyl cellulose (SCMC) to the pharmaceutical industry world-wide.
The transaction is expected to position DMV-Fonterra Excipients as the sole manufacturer and supplier of the most commonly used diluents and superdisintegrants in the Pharmaceutical industry.
The acquisition will also improve DMV-Fonterra Excipients’ ability to support its customers with reducing their supply chain and formulation costs by having a consistent, single source and single quality framework across their key products.
The legal implementation is planned to be formalized in Q4 2011 – but is subject to official approval by the Indian authorities and other approvals.
DMV-Fonterra Excipients is a 50/50 joint venture between Dutch dairy company Royal FrieslandCampina and New Zealand dairy company Fonterra.